Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.0919444055175058e-22,87.85150078988941,4442.554819587456,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.592497094152594e-20,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.563982762546147e-13,inf,inf,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",2.5727516443884118e-11,0,0,37
3,Oxidative phosphorylation WP623,6.177054090782849e-08,inf,inf,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF']",6.774169319558525e-06,0,0,21
4,Nonalcoholic fatty liver disease WP4396,4.37834594815798e-07,6.802848575712144,99.60339472664582,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",3.601189542359939e-05,0,0,33
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.3195712600165407e-06,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.00021842778890908838,0,0,16
6,Mitochondrial CIV Assembly WP4922,1.6246501919432587e-05,inf,inf,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.0008908498552488869,0,0,14
7,Mitochondrial complex III assembly WP4921,0.0041091292661217345,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1']",0.19312907550772151,0,0,7
8,Amino Acid metabolism WP3925,0.009029461282571757,inf,inf,"['LDHA', 'PKM', 'GOT1', 'GSS', 'ODC1', 'SRM']",0.3300769735517898,0,0,6
9,Glycolysis and Gluconeogenesis WP534,0.009029461282571757,inf,inf,"['LDHA', 'PKM', 'GOT1', 'PGAM1', 'ALDOC', 'PFKM']",0.3300769735517898,0,0,6
10,Pathways in clear cell renal cell carcinoma WP4018,0.01982590288092656,inf,inf,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.6522722047824838,0,0,5
11,Pancreatic adenocarcinoma pathway WP4263,0.03855152078798594,7.175792507204611,23.362656275776132,"['TGFB1', 'CDKN2A', 'PRKCD', 'BAX', 'PLD1', 'GADD45G']",0.9978332419385398,0,0,6
12,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.043497462255429234,inf,inf,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9978332419385398,0,0,4
13,7q11.23 copy number variation syndrome WP4932,0.07380817905634265,5.971223021582734,15.56271332907739,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.9978332419385398,0,0,5
14,Acute viral myocarditis WP4298,0.07380817905634265,5.971223021582734,15.56271332907739,"['ENDOG', 'TGFB1', 'CASP6', 'CYCS', 'BAX']",0.9978332419385398,0,0,5
15,Ferroptosis WP4313,0.09482564353159048,3.5835734870317,8.441879268034718,"['MAP1LC3A', 'GPX4', 'GSS', 'VDAC3', 'SAT2', 'FTL']",0.9978332419385398,0,0,6
16,Cellular Proteostasis WP4918,0.09535761661569174,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.9978332419385398,0,0,3
17,Type 2 papillary renal cell carcinoma WP4241,0.09535761661569174,inf,inf,"['TGFB1', 'COL21A1', 'ELOB']",0.9978332419385398,0,0,3
18,Computational Model of Aerobic Glycolysis WP4629,0.09535761661569174,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.9978332419385398,0,0,3
19,Glycolysis in senescence WP5049,0.09535761661569174,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.9978332419385398,0,0,3
20,mRNA Processing WP411,0.10985273125039138,2.787878787878788,6.157349841352532,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'SNRPE', 'SNU13', 'SRSF9']",0.9978332419385398,0,0,7
21,Base Excision Repair WP4752,0.13818373537512102,4.7701149425287355,9.440873464352354,"['POLE4', 'NEIL2', 'APEX1', 'POLE2']",0.9978332419385398,0,0,4
22,Corticotropin-releasing hormone signaling pathway WP2355,0.13818373537512102,4.7701149425287355,9.440873464352354,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9978332419385398,0,0,4
23,DNA IR-double strand breaks and cellular response via ATM WP3959,0.13818373537512102,4.7701149425287355,9.440873464352354,"['DCLRE1C', 'KAT5', 'CDKN2A', 'BAX']",0.9978332419385398,0,0,4
24,Nanomaterial induced apoptosis WP2507,0.13818373537512102,4.7701149425287355,9.440873464352354,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.9978332419385398,0,0,4
25,Rett syndrome causing genes WP4312,0.13818373537512102,4.7701149425287355,9.440873464352354,"['KCNJ10', 'IMPDH2', 'HAP1', 'GABRD']",0.9978332419385398,0,0,4
26,Fragile X Syndrome  WP4549,0.16194985152918423,2.9820143884892087,5.428663410293733,"['PRKAR1A', 'CDKN2A', 'PPP2R5B', 'SLC6A1', 'GABRD']",0.9978332419385398,0,0,5
27,Proteasome Degradation WP183,0.17650879959185145,2.3861671469740635,4.138531428196704,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9978332419385398,0,0,6
28,DNA Repair Pathways Full Network WP4946,0.18588705560625235,2.0883838383838382,3.513948097423961,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'POLE2', 'APEX1']",0.9978332419385398,0,0,7
29,Amyotrophic lateral sclerosis (ALS) WP2447,0.20888540012847284,inf,inf,"['TOMM40', 'BAX']",0.9978332419385398,0,0,2
30,Apoptosis Modulation by HSP70 WP384,0.20888540012847284,inf,inf,"['CASP6', 'CYCS']",0.9978332419385398,0,0,2
31,CAMKK2  Pathway WP4874,0.20888540012847284,inf,inf,"['FIS1', 'MAP1LC3A']",0.9978332419385398,0,0,2
32,Type II diabetes mellitus WP1584,0.20888540012847284,inf,inf,"['SURF1', 'PRKCD']",0.9978332419385398,0,0,2
33,Urea cycle and metabolism of amino groups WP497,0.20888540012847284,inf,inf,"['ODC1', 'SRM']",0.9978332419385398,0,0,2
34,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.20888540012847284,inf,inf,"['TGFB1', 'VIP']",0.9978332419385398,0,0,2
35,Cori Cycle WP1946,0.20888540012847284,inf,inf,"['LDHA', 'PGAM1']",0.9978332419385398,0,0,2
36,Dual hijack model of Vif in HIV infection WP3300,0.20888540012847284,inf,inf,"['ELOB', 'RUNX1']",0.9978332419385398,0,0,2
37,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.20888540012847284,inf,inf,"['H3F3B', 'H2AFZ']",0.9978332419385398,0,0,2
38,Gastric acid production WP2596,0.20888540012847284,inf,inf,"['CCK', 'VIP']",0.9978332419385398,0,0,2
39,Glutathione metabolism WP100,0.20888540012847284,inf,inf,"['GPX4', 'GSS']",0.9978332419385398,0,0,2
40,Hematopoietic Stem Cell Differentiation WP2849,0.20888540012847284,inf,inf,"['PIM1', 'RUNX1']",0.9978332419385398,0,0,2
41,Histone Modifications WP2369,0.20888540012847284,inf,inf,"['SET', 'H3F3B']",0.9978332419385398,0,0,2
42,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.20888540012847284,inf,inf,"['SFRP1', 'TGFB1']",0.9978332419385398,0,0,2
43,NO/cGMP/PKG mediated Neuroprotection WP4008,0.20888540012847284,inf,inf,"['PDE3A', 'CYCS']",0.9978332419385398,0,0,2
44,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.20888540012847284,inf,inf,"['EIF3I', 'EIF3D']",0.9978332419385398,0,0,2
45,Osteoclast Signaling WP12,0.20888540012847284,inf,inf,"['AIMP2', 'ATP6V1G1']",0.9978332419385398,0,0,2
46,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.20888540012847284,inf,inf,"['TGFB1', 'BAX']",0.9978332419385398,0,0,2
47,SARS-CoV-2 mitochondrial interactions WP5038,0.20888540012847284,inf,inf,"['NDUFB9', 'PHB']",0.9978332419385398,0,0,2
48,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.25093802406812127,3.5724533715925393,4.939092859601131,"['SFRP1', 'SST', 'DCN']",0.9978332419385398,0,0,3
49,Differentiation Pathway WP2848,0.25093802406812127,3.5724533715925393,4.939092859601131,"['TGFB1', 'KIT', 'FGF1']",0.9978332419385398,0,0,3
50,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.25093802406812127,3.5724533715925393,4.939092859601131,"['MAP1LC3A', 'IGFBP5', 'PLD1']",0.9978332419385398,0,0,3
51,Glycosylation and related congenital defects WP4521,0.25093802406812127,3.5724533715925393,4.939092859601131,"['DPM3', 'MAGT1', 'MPDU1']",0.9978332419385398,0,0,3
52,Metabolic reprogramming in colon cancer WP4290,0.25093802406812127,3.5724533715925393,4.939092859601131,"['LDHA', 'PKM', 'PGAM1']",0.9978332419385398,0,0,3
53,Nucleotide metabolism WP404,0.25093802406812127,3.5724533715925393,4.939092859601131,"['NME2', 'OAZ1', 'SRM']",0.9978332419385398,0,0,3
54,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.25093802406812127,3.5724533715925393,4.939092859601131,"['HSP90AA1', 'CDKN2A', 'BAX']",0.9978332419385398,0,0,3
55,Prader-Willi and Angelman Syndrome WP3998,0.25093802406812127,3.5724533715925393,4.939092859601131,"['DLX5', 'CDKN2A', 'GABRD']",0.9978332419385398,0,0,3
56,Aryl Hydrocarbon Receptor Pathway WP2873,0.2669348257922649,2.382183908045977,3.146271179699762,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9978332419385398,0,0,4
57,Translation Factors WP107,0.2669348257922649,2.382183908045977,3.146271179699762,"['EEF1B2', 'EIF3I', 'EIF4H', 'EIF3D']",0.9978332419385398,0,0,4
58,Eukaryotic Transcription Initiation WP405,0.2669348257922649,2.382183908045977,3.146271179699762,"['GTF2A2', 'TAF13', 'POLR2I', 'POLR2K']",0.9978332419385398,0,0,4
59,GABA receptor Signaling WP4159,0.2669348257922649,2.382183908045977,3.146271179699762,"['GABBR1', 'SLC32A1', 'SLC6A1', 'GABRD']",0.9978332419385398,0,0,4
60,Neural Crest Differentiation WP2064,0.2669348257922649,2.382183908045977,3.146271179699762,"['DLX5', 'LHX2', 'FGFR2', 'GFAP']",0.9978332419385398,0,0,4
61,Apoptosis WP254,0.27382351819081974,1.985611510791367,2.5719059489815645,"['HRK', 'CASP6', 'CDKN2A', 'CYCS', 'BAX']",0.9978332419385398,0,0,5
62,Cell cycle WP179,0.27382351819081974,1.985611510791367,2.5719059489815645,"['TGFB1', 'CDKN2A', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9978332419385398,0,0,5
63,Modulators of TCR signaling and T cell activation WP5072,0.27382351819081974,1.985611510791367,2.5719059489815645,"['FIBP', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7']",0.9978332419385398,0,0,5
64,Proximal tubule transport WP4917,0.27382351819081974,1.985611510791367,2.5719059489815645,"['ATP6V1G1', 'ATP1A1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.9978332419385398,0,0,5
65,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2832023705745795,1.2515802781289507,1.5789856018450183,"['HSP90AA1', 'SET', 'TRPC3', 'PRKCD', 'RPL13A', 'RPL10A', 'RPL7', 'DNAJA1', 'SCUBE2', 'LDHA', 'RCN1', 'RPL18A', 'TMSB4X', 'RPLP2', 'DNAJB9', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'ARF6']",0.9978332419385398,0,0,22
66,Ciliary landscape WP4352,0.38521986065331504,1.4282420749279539,1.362458731840843,"['PSMD8', 'VPS4A', 'COPS7A', 'MYL6B', 'WDR34', 'LSM4']",0.9978332419385398,0,0,6
67,22q11.2 copy number variation syndrome WP4657,0.4069147299162521,1.5862068965517242,1.426240507502184,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9978332419385398,0,0,4
68,Synaptic Vesicle Pathway WP2267,0.4069147299162521,1.5862068965517242,1.426240507502184,"['RAB3A', 'SLC32A1', 'PARK7', 'CPLX3']",0.9978332419385398,0,0,4
69,Cardiac Progenitor Differentiation WP2406,0.4069147299162521,1.5862068965517242,1.426240507502184,"['MESP1', 'TGFB1', 'KIT', 'ROR2']",0.9978332419385398,0,0,4
70,Endometrial cancer WP4155,0.4069147299162521,1.5862068965517242,1.426240507502184,"['BAX', 'FGF1', 'FGFR2', 'GADD45G']",0.9978332419385398,0,0,4
71,Hippo-Merlin Signaling Dysregulation WP4541,0.4069147299162521,1.5862068965517242,1.426240507502184,"['PPP1R14A', 'PRKAR1A', 'KIT', 'FGFR2']",0.9978332419385398,0,0,4
72,Melanoma WP4685,0.4069147299162521,1.5862068965517242,1.426240507502184,"['CDKN2A', 'KIT', 'BAX', 'GADD45G']",0.9978332419385398,0,0,4
73,Non-small cell lung cancer WP4255,0.4069147299162521,1.5862068965517242,1.426240507502184,"['CDKN2A', 'CYCS', 'BAX', 'GADD45G']",0.9978332419385398,0,0,4
74,Alzheimer's disease WP2059,0.4200693571674296,1.784074605451937,1.5473911422347402,"['ATP5MD', 'CYCS', 'APOE']",0.9978332419385398,0,0,3
75,TP53 network WP1742,0.4200693571674296,1.784074605451937,1.5473911422347402,"['SUMO1', 'CDKN2A', 'BAX']",0.9978332419385398,0,0,3
76,Complement system WP2806,0.4200693571674296,1.784074605451937,1.5473911422347402,"['RPS19', 'CD59', 'DCN']",0.9978332419385398,0,0,3
77,Zinc homeostasis WP3529,0.4200693571674296,1.784074605451937,1.5473911422347402,"['SLC39A11', 'SLC39A7', 'SLC39A3']",0.9978332419385398,0,0,3
78,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4200693571674296,1.784074605451937,1.5473911422347402,"['LDHA', 'PKM', 'BAX']",0.9978332419385398,0,0,3
79,ACE Inhibitor Pathway WP554,0.43594075815789174,2.378223495702006,1.9745174903703597,"['TGFB1', 'ATP6AP2']",0.9978332419385398,0,0,2
80,BMP Signaling Pathway in Eyelid Development WP3927,0.43594075815789174,2.378223495702006,1.9745174903703597,"['SFRP1', 'FGFR2']",0.9978332419385398,0,0,2
81,Cell migration and invasion through p75NTR WP4561,0.43594075815789174,2.378223495702006,1.9745174903703597,"['EFNA3', 'EFNB3']",0.9978332419385398,0,0,2
82,Type II interferon signaling (IFNG) WP619,0.43594075815789174,2.378223495702006,1.9745174903703597,"['PRKCD', 'HLA-B']",0.9978332419385398,0,0,2
83,Vitamin D-sensitive calcium signaling in depression WP4698,0.43594075815789174,2.378223495702006,1.9745174903703597,"['GPX4', 'PVALB']",0.9978332419385398,0,0,2
84,White fat cell differentiation WP4149,0.43594075815789174,2.378223495702006,1.9745174903703597,"['DDIT3', 'NR2F2']",0.9978332419385398,0,0,2
85,Cysteine and methionine catabolism WP4504,0.43594075815789174,2.378223495702006,1.9745174903703597,"['GOT1', 'GSS']",0.9978332419385398,0,0,2
86,Glycogen Synthesis and Degradation WP500,0.43594075815789174,2.378223495702006,1.9745174903703597,"['PHKG1', 'PPP2R5B']",0.9978332419385398,0,0,2
87,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.43594075815789174,2.378223495702006,1.9745174903703597,"['FGF1', 'FGFR2']",0.9978332419385398,0,0,2
88,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.43594075815789174,2.378223495702006,1.9745174903703597,"['IFITM3', 'DDIT3']",0.9978332419385398,0,0,2
89,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.43594075815789174,2.378223495702006,1.9745174903703597,"['FGFR2', 'GADD45G']",0.9978332419385398,0,0,2
90,Neovascularisation processes WP4331,0.43594075815789174,2.378223495702006,1.9745174903703597,"['TGFB1', 'KIT']",0.9978332419385398,0,0,2
91,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.43594075815789174,2.378223495702006,1.9745174903703597,"['MAP1LC3A', 'FTL']",0.9978332419385398,0,0,2
92,Pre-implantation embryo WP3527,0.43594075815789174,2.378223495702006,1.9745174903703597,"['DDIT3', 'ATP1A1']",0.9978332419385398,0,0,2
93,Pregnane X receptor pathway WP2876,0.43594075815789174,2.378223495702006,1.9745174903703597,"['HSP90AA1', 'PSMC5']",0.9978332419385398,0,0,2
94,15q11.2 copy number variation syndrome WP4940,0.4572173713476312,inf,inf,['TUBGCP4'],0.9978332419385398,0,0,1
95,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4572173713476312,inf,inf,['TGFB1'],0.9978332419385398,0,0,1
96,16p11.2 distal deletion syndrome WP4950,0.4572173713476312,inf,inf,['CD81'],0.9978332419385398,0,0,1
97,Serotonin and anxiety WP3947,0.4572173713476312,inf,inf,['CRH'],0.9978332419385398,0,0,1
98,Serotonin and anxiety-related events WP3944,0.4572173713476312,inf,inf,['CRH'],0.9978332419385398,0,0,1
99,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.4572173713476312,inf,inf,['APOE'],0.9978332419385398,0,0,1
100,TCA cycle in senescence WP5050,0.4572173713476312,inf,inf,['GOT1'],0.9978332419385398,0,0,1
101,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.4572173713476312,inf,inf,['TGFB1'],0.9978332419385398,0,0,1
102,Biomarkers for urea cycle disorders WP4583,0.4572173713476312,inf,inf,['GOT1'],0.9978332419385398,0,0,1
103,Thiamine metabolic pathways WP4297,0.4572173713476312,inf,inf,['BCKDK'],0.9978332419385398,0,0,1
104,Cannabinoid receptor signaling WP3869,0.4572173713476312,inf,inf,['PRKAR1A'],0.9978332419385398,0,0,1
105,Canonical and non-canonical TGF-B signaling WP3874,0.4572173713476312,inf,inf,['TGFB1'],0.9978332419385398,0,0,1
106,Urea cycle and associated pathways WP4595,0.4572173713476312,inf,inf,['GOT1'],0.9978332419385398,0,0,1
107,Vitamin D in inflammatory diseases WP4482,0.4572173713476312,inf,inf,['DUSP1'],0.9978332419385398,0,0,1
108,Wnt Signaling Pathway WP363,0.4572173713476312,inf,inf,['ROR2'],0.9978332419385398,0,0,1
109,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4572173713476312,inf,inf,['RPH3AL'],0.9978332419385398,0,0,1
110,Ebstein-Barr virus LMP1 signaling WP262,0.4572173713476312,inf,inf,['HSP90AA1'],0.9978332419385398,0,0,1
111,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.4572173713476312,inf,inf,['H3F3B'],0.9978332419385398,0,0,1
112,Energy Metabolism WP1541,0.4572173713476312,inf,inf,['PPRC1'],0.9978332419385398,0,0,1
113,EV release from cardiac cells and their functional effects WP3297,0.4572173713476312,inf,inf,['RGS16'],0.9978332419385398,0,0,1
114,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4572173713476312,inf,inf,['SGK1'],0.9978332419385398,0,0,1
115,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.4572173713476312,inf,inf,['GSS'],0.9978332419385398,0,0,1
116,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4572173713476312,inf,inf,['GABBR1'],0.9978332419385398,0,0,1
117,Heart Development WP1591,0.4572173713476312,inf,inf,['VEGFB'],0.9978332419385398,0,0,1
118,HIF1A and PPARG regulation of glycolysis WP2456,0.4572173713476312,inf,inf,['LDHA'],0.9978332419385398,0,0,1
119,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.4572173713476312,inf,inf,['ELOB'],0.9978332419385398,0,0,1
120,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.4572173713476312,inf,inf,['MAP1LC3A'],0.9978332419385398,0,0,1
121,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.4572173713476312,inf,inf,['TGFB1'],0.9978332419385398,0,0,1
122,Intraflagellar transport proteins binding to dynein WP4532,0.4572173713476312,inf,inf,['WDR34'],0.9978332419385398,0,0,1
123,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.4572173713476312,inf,inf,['GABRD'],0.9978332419385398,0,0,1
124,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4572173713476312,inf,inf,['VEGFB'],0.9978332419385398,0,0,1
125,Mitochondrial fatty acid synthesis pathway WP4317,0.4572173713476312,inf,inf,['HSD17B12'],0.9978332419385398,0,0,1
126,Mitochondrial Gene Expression WP391,0.4572173713476312,inf,inf,['PPRC1'],0.9978332419385398,0,0,1
127,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4572173713476312,inf,inf,['GOT1'],0.9978332419385398,0,0,1
128,NAD+ metabolism WP3644,0.4572173713476312,inf,inf,['NMNAT1'],0.9978332419385398,0,0,1
129,Nanoparticle triggered autophagic cell death WP2509,0.4572173713476312,inf,inf,['MAP1LC3A'],0.9978332419385398,0,0,1
130,Nanoparticle triggered regulated necrosis WP2513,0.4572173713476312,inf,inf,['FTL'],0.9978332419385398,0,0,1
131,Non-homologous end joining WP438,0.4572173713476312,inf,inf,['DCLRE1C'],0.9978332419385398,0,0,1
132,Oxidative Stress WP408,0.4572173713476312,inf,inf,['TXN2'],0.9978332419385398,0,0,1
133,Peroxiredoxin 2 induced ovarian failure WP4873,0.4572173713476312,inf,inf,['BAX'],0.9978332419385398,0,0,1
134,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4572173713476312,inf,inf,['LDHA'],0.9978332419385398,0,0,1
135,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4572173713476312,inf,inf,['TGFB1'],0.9978332419385398,0,0,1
136,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4572173713476312,inf,inf,['ANAPC11'],0.9978332419385398,0,0,1
137,Selenium Micronutrient Network WP15,0.49354148998687036,1.1887608069164266,0.8394414832055711,"['SELENOM', 'GPX4', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9978332419385398,0,0,6
138,Spinal Cord Injury WP2431,0.49354148998687036,1.1887608069164266,0.8394414832055711,"['TGFB1', 'APEX1', 'OMG', 'AQP4', 'SLIT3', 'GFAP']",0.9978332419385398,0,0,6
139,Pyrimidine metabolism WP4022,0.49354148998687036,1.1887608069164266,0.8394414832055711,"['POLE4', 'POLE2', 'NME2', 'POLR2I', 'POLR2K', 'POLR2L']",0.9978332419385398,0,0,6
140,Hepatitis B infection WP4666,0.5144407856018756,1.1884892086330936,0.7899588525842718,"['TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'BAX']",0.9978332419385398,0,0,5
141,Integrated breast cancer pathway WP1984,0.5144407856018756,1.1884892086330936,0.7899588525842718,"['ODC1', 'BAX', 'PHB', 'FAU', 'JAKMIP1']",0.9978332419385398,0,0,5
142,Ras signaling WP4223,0.5144407856018756,1.1884892086330936,0.7899588525842718,"['GNG4', 'KIT', 'PLD1', 'FGFR2', 'ARF6']",0.9978332419385398,0,0,5
143,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5400058557779681,1.1882183908045978,0.7321508180123609,"['TGFB1', 'CYCS', 'BAX', 'GADD45G']",0.9978332419385398,0,0,4
144,Pathways Regulating Hippo Signaling WP4540,0.5400058557779681,1.1882183908045978,0.7321508180123609,"['PRKAR1A', 'PRKCD', 'KIT', 'FGFR2']",0.9978332419385398,0,0,4
145,MAPK Signaling Pathway WP382,0.5707429661604686,1.0391414141414141,0.5827674612425335,"['DUSP4', 'TGFB1', 'DUSP1', 'DDIT3', 'PRKCD', 'FGF1', 'FGFR2']",0.9978332419385398,0,0,7
146,16p11.2 proximal deletion syndrome WP4949,0.5732037682824257,1.187948350071736,0.6611098987064252,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9978332419385398,0,0,3
147,DNA damage response WP707,0.5732037682824257,1.187948350071736,0.6611098987064252,"['CYCS', 'BAX', 'GADD45G']",0.9978332419385398,0,0,3
148,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5732037682824257,1.187948350071736,0.6611098987064252,"['CASP6', 'RIPK2', 'CYCS']",0.9978332419385398,0,0,3
149,One-carbon metabolism and related pathways WP3940,0.5732037682824257,1.187948350071736,0.6611098987064252,"['GPX4', 'GSS', 'PLD1']",0.9978332419385398,0,0,3
150,Parkinson's disease pathway WP2371,0.5732037682824257,1.187948350071736,0.6611098987064252,"['CASP6', 'CYCS', 'PARK7']",0.9978332419385398,0,0,3
151,PI3K-Akt signaling pathway WP4172,0.5925948474132371,0.9891304347826086,0.5175569002971455,"['EFNA3', 'HSP90AA1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'PPP2R5B', 'SGK1', 'FGF1', 'FGFR2']",0.9978332419385398,0,0,10
152,Apoptosis Modulation and Signaling WP1772,0.5943958133786275,1.0177027583367642,0.5294189779324472,"['HRK', 'ENDOG', 'CASP6', 'CDKN2A', 'CYCS', 'BAX']",0.9978332419385398,0,0,6
153,IL-18 signaling pathway WP4754,0.6103201595673389,0.9638828238719068,0.47593797162733487,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'NDUFC1', 'PLD1', 'TMSB4X', 'RFX5', 'CYCS', 'BAX', 'ARF6']",0.9978332419385398,0,0,13
154,3q29 copy number variation syndrome WP4906,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['TGFB1', 'WDR34']",0.9978332419385398,0,0,2
155,AGE/RAGE pathway WP2324,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['PRKCD', 'CYCS']",0.9978332419385398,0,0,2
156,Cardiac Hypertrophic Response WP2795,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['TGFB1', 'FGFR2']",0.9978332419385398,0,0,2
157,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['PRKCD', 'PIM1']",0.9978332419385398,0,0,2
158,Tumor suppressor activity of SMARCB1 WP4204,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['H3F3B', 'CDKN2A']",0.9978332419385398,0,0,2
159,Copper homeostasis WP3286,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['COX17', 'ATOX1']",0.9978332419385398,0,0,2
160,Cytosolic DNA-sensing pathway WP4655,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['POLR2K', 'POLR2L']",0.9978332419385398,0,0,2
161,DNA Mismatch Repair WP531,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['POLE4', 'POLE2']",0.9978332419385398,0,0,2
162,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['TGFB1', 'BANF1']",0.9978332419385398,0,0,2
163,Mesodermal commitment pathway WP2857,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['PRKAR1A', 'RPL38']",0.9978332419385398,0,0,2
164,Methionine De Novo and Salvage Pathway WP3580,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['ODC1', 'SRM']",0.9978332419385398,0,0,2
165,Nucleotide Excision Repair WP4753,0.6209432997255179,1.1876790830945558,0.5659474992547566,"['POLE4', 'POLE2']",0.9978332419385398,0,0,2
166,Ectoderm Differentiation WP2858,0.622124807947857,0.9892086330935251,0.4694928107532593,"['PIM1', 'ROR2', 'NR2F2', 'JAKMIP1', 'FGFR2']",0.9978332419385398,0,0,5
167,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6445340035026258,0.9316815260211486,0.40922033239718436,"['EFNA3', 'HSP90AA1', 'COL5A1', 'PIK3IP1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'PPP2R5B', 'FGF1', 'FGFR2']",0.9978332419385398,0,0,11
168,T-cell receptor (TCR) signaling pathway WP69,0.6556369417540676,0.9494252873563218,0.4007980675649695,"['TGFB1', 'RIPK2', 'PRKCD', 'LCP2']",0.9978332419385398,0,0,4
169,Gastrin signaling pathway WP4659,0.6556369417540676,0.9494252873563218,0.4007980675649695,"['KAT5', 'CDKN2A', 'PRKCD', 'KIT']",0.9978332419385398,0,0,4
170,Small cell lung cancer WP4658,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['CYCS', 'BAX', 'GADD45G']",0.9978332419385398,0,0,3
171,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['PDGFC', 'BAX', 'FGFR2']",0.9978332419385398,0,0,3
172,Endoderm differentiation WP2853,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['DUSP4', 'SFRP1', 'TGFB1']",0.9978332419385398,0,0,3
173,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['PPP1R14A', 'MAP1LC3A', 'DDIT3']",0.9978332419385398,0,0,3
174,MECP2 and Associated Rett Syndrome WP3584,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['DLX5', 'SST', 'SGK1']",0.9978332419385398,0,0,3
175,miRNA regulation of DNA damage response WP1530,0.6979204161513003,0.8898852223816356,0.32004739793554826,"['CYCS', 'BAX', 'GADD45G']",0.9978332419385398,0,0,3
176,Signal transduction through IL1R WP4496,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TGFB1'],0.9978332419385398,0,0,1
177,Splicing factor NOVA regulated synaptic proteins WP4148,0.7055490051432232,1.1874105865522175,0.4141439345846405,['NTNG1'],0.9978332419385398,0,0,1
178,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7055490051432232,1.1874105865522175,0.4141439345846405,['LCP2'],0.9978332419385398,0,0,1
179,Trans-sulfuration and one-carbon metabolism WP2525,0.7055490051432232,1.1874105865522175,0.4141439345846405,['GSS'],0.9978332419385398,0,0,1
180,Trans-sulfuration pathway WP2333,0.7055490051432232,1.1874105865522175,0.4141439345846405,['GOT1'],0.9978332419385398,0,0,1
181,Transcription co-factors SKI and SKIL protein partners WP4533,0.7055490051432232,1.1874105865522175,0.4141439345846405,['MERTK'],0.9978332419385398,0,0,1
182,Transcriptional cascade regulating adipogenesis WP4211,0.7055490051432232,1.1874105865522175,0.4141439345846405,['DDIT3'],0.9978332419385398,0,0,1
183,Tryptophan catabolism leading to NAD+ production WP4210,0.7055490051432232,1.1874105865522175,0.4141439345846405,['NMNAT1'],0.9978332419385398,0,0,1
184,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7055490051432232,1.1874105865522175,0.4141439345846405,['CCK'],0.9978332419385398,0,0,1
185,Composition of Lipid Particles WP3601,0.7055490051432232,1.1874105865522175,0.4141439345846405,['APOE'],0.9978332419385398,0,0,1
186,Constitutive Androstane Receptor Pathway WP2875,0.7055490051432232,1.1874105865522175,0.4141439345846405,['HSP90AA1'],0.9978332419385398,0,0,1
187,Cytokines and Inflammatory Response WP530,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TGFB1'],0.9978332419385398,0,0,1
188,Dopaminergic Neurogenesis WP2855,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TGFB1'],0.9978332419385398,0,0,1
189,Fatty acid transporters WP5061,0.7055490051432232,1.1874105865522175,0.4141439345846405,['FABP3'],0.9978332419385398,0,0,1
190,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7055490051432232,1.1874105865522175,0.4141439345846405,['FGFR2'],0.9978332419385398,0,0,1
191,Galanin receptor pathway WP4970,0.7055490051432232,1.1874105865522175,0.4141439345846405,['PRKCD'],0.9978332419385398,0,0,1
192,Gastric Cancer Network 2 WP2363,0.7055490051432232,1.1874105865522175,0.4141439345846405,['FANCI'],0.9978332419385398,0,0,1
193,Genes targeted by miRNAs in adipocytes WP1992,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TMSB4X'],0.9978332419385398,0,0,1
194,Glycerolipids and Glycerophospholipids WP4722,0.7055490051432232,1.1874105865522175,0.4141439345846405,['PLD1'],0.9978332419385398,0,0,1
195,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TGFB1'],0.9978332419385398,0,0,1
196,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7055490051432232,1.1874105865522175,0.4141439345846405,['LDHA'],0.9978332419385398,0,0,1
197,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7055490051432232,1.1874105865522175,0.4141439345846405,['BAX'],0.9978332419385398,0,0,1
198,Joubert Syndrome WP4656,0.7055490051432232,1.1874105865522175,0.4141439345846405,['KAT5'],0.9978332419385398,0,0,1
199,Kit receptor signaling pathway WP304,0.7055490051432232,1.1874105865522175,0.4141439345846405,['KIT'],0.9978332419385398,0,0,1
200,Lipid Metabolism Pathway WP3965,0.7055490051432232,1.1874105865522175,0.4141439345846405,['PRKAR1A'],0.9978332419385398,0,0,1
201,Mammalian disorder of sexual development WP4842,0.7055490051432232,1.1874105865522175,0.4141439345846405,['FGFR2'],0.9978332419385398,0,0,1
202,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7055490051432232,1.1874105865522175,0.4141439345846405,['BAX'],0.9978332419385398,0,0,1
203,Melatonin metabolism and effects WP3298,0.7055490051432232,1.1874105865522175,0.4141439345846405,['APOE'],0.9978332419385398,0,0,1
204,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.7055490051432232,1.1874105865522175,0.4141439345846405,['APOE'],0.9978332419385398,0,0,1
205,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7055490051432232,1.1874105865522175,0.4141439345846405,['BAX'],0.9978332419385398,0,0,1
206,Monoamine Transport WP727,0.7055490051432232,1.1874105865522175,0.4141439345846405,['SLC6A1'],0.9978332419385398,0,0,1
207,MTHFR deficiency WP4288,0.7055490051432232,1.1874105865522175,0.4141439345846405,['CYCS'],0.9978332419385398,0,0,1
208,NAD Biosynthesis II (from tryptophan) WP2485,0.7055490051432232,1.1874105865522175,0.4141439345846405,['NMNAT1'],0.9978332419385398,0,0,1
209,NAD+ biosynthetic pathways WP3645,0.7055490051432232,1.1874105865522175,0.4141439345846405,['NMNAT1'],0.9978332419385398,0,0,1
210,Neural Crest Cell Migration during Development WP4564,0.7055490051432232,1.1874105865522175,0.4141439345846405,['EPHB3'],0.9978332419385398,0,0,1
211,Neural Crest Cell Migration in Cancer WP4565,0.7055490051432232,1.1874105865522175,0.4141439345846405,['EPHB3'],0.9978332419385398,0,0,1
212,Overview of nanoparticle effects WP3287,0.7055490051432232,1.1874105865522175,0.4141439345846405,['BAX'],0.9978332419385398,0,0,1
213,Oxidation by Cytochrome P450 WP43,0.7055490051432232,1.1874105865522175,0.4141439345846405,['CYB5R1'],0.9978332419385398,0,0,1
214,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TRPC3'],0.9978332419385398,0,0,1
215,Purinergic signaling WP4900,0.7055490051432232,1.1874105865522175,0.4141439345846405,['P2RY14'],0.9978332419385398,0,0,1
216,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7055490051432232,1.1874105865522175,0.4141439345846405,['TGFB1'],0.9978332419385398,0,0,1
217,NRF2 pathway WP2884,0.7312550443199706,0.8292929292929293,0.259562867093687,"['HSP90AA1', 'TGFB1', 'SLC39A11', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9978332419385398,0,0,7
218,Androgen receptor signaling pathway WP138,0.7497676021650688,0.7902298850574713,0.2275798726108684,"['SUMO1', 'KAT5', 'PARK7', 'FKBP4']",0.9978332419385398,0,0,4
219,EGF/EGFR signaling pathway WP437,0.7497676021650688,0.7902298850574713,0.2275798726108684,"['NDUFA13', 'PRKCD', 'PLD1', 'ARF6']",0.9978332419385398,0,0,4
220,Aryl Hydrocarbon Receptor Netpath WP2586,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['HSP90AA1', 'AIP']",0.9978332419385398,0,0,2
221,ATM Signaling Network in Development and Disease  WP3878,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['DCLRE1C', 'KAT5']",0.9978332419385398,0,0,2
222,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['APEX1', 'PLD1']",0.9978332419385398,0,0,2
223,TNF-alpha signaling pathway WP231,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['HSP90AA1', 'BAX']",0.9978332419385398,0,0,2
224,G1 to S cell cycle control WP45,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['CDKN2A', 'POLE2']",0.9978332419385398,0,0,2
225,IL-6 signaling pathway WP364,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['PRKCD', 'VIP']",0.9978332419385398,0,0,2
226,Lung fibrosis WP3624,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['TGFB1', 'FGF1']",0.9978332419385398,0,0,2
227,Peptide GPCRs WP24,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['MC1R', 'ACKR1']",0.9978332419385398,0,0,2
228,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['BAX', 'ANGPTL1']",0.9978332419385398,0,0,2
229,Retinoblastoma gene in cancer WP2446,0.7548590788201079,0.7908309455587392,0.2224007981999827,"['H2AFZ', 'POLE2']",0.9978332419385398,0,0,2
230,Myometrial relaxation and contraction pathways WP289,0.7584338469053893,0.7896253602305475,0.21833117496252108,"['IGFBP5', 'PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'CRH']",0.9978332419385398,0,0,6
231,Calcium Regulation in the Cardiac Cell WP536,0.7887036755737594,0.7401079136690647,0.1756754176231569,"['PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'ATP1B2']",0.9978332419385398,0,0,5
232,Allograft Rejection WP2328,0.7926690160818152,0.7110473457675753,0.16521151408367618,"['TGFB1', 'COL5A1', 'HLA-B']",0.9978332419385398,0,0,3
233,Exercise-induced Circadian Regulation WP410,0.7926690160818152,0.7110473457675753,0.16521151408367618,"['DNAJA1', 'DAZAP2', 'SUMO1']",0.9978332419385398,0,0,3
234,Glioblastoma signaling pathways WP2261,0.7926690160818152,0.7110473457675753,0.16521151408367618,"['CDKN2A', 'PRKCD', 'FGFR2']",0.9978332419385398,0,0,3
235,Senescence and Autophagy in Cancer WP615,0.7937659333274574,0.7529843893480257,0.17391428604637416,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'IGFBP5', 'CDKN2A', 'GABARAP', 'SLC39A3']",0.9978332419385398,0,0,7
236,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8227062265153422,0.6765188834154351,0.13202678445855898,"['BEX3', 'RIPK2', 'RNF7', 'APOE']",0.9978332419385398,0,0,4
237,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8403528516640444,0.5929899856938483,0.1031407725853148,['TGFB1'],0.9978332419385398,0,0,1
238,Sleep regulation WP3591,0.8403528516640444,0.5929899856938483,0.1031407725853148,['CRH'],0.9978332419385398,0,0,1
239,Airway smooth muscle cell contraction WP4962,0.8403528516640444,0.5929899856938483,0.1031407725853148,['PPP1R14A'],0.9978332419385398,0,0,1
240,Alanine and aspartate metabolism WP106,0.8403528516640444,0.5929899856938483,0.1031407725853148,['GOT1'],0.9978332419385398,0,0,1
241,Alpha 6 Beta 4 signaling pathway WP244,0.8403528516640444,0.5929899856938483,0.1031407725853148,['PRKCD'],0.9978332419385398,0,0,1
242,Angiogenesis WP1539,0.8403528516640444,0.5929899856938483,0.1031407725853148,['FGFR2'],0.9978332419385398,0,0,1
243,Vitamin B12 metabolism WP1533,0.8403528516640444,0.5929899856938483,0.1031407725853148,['APOE'],0.9978332419385398,0,0,1
244,Development and heterogeneity of the ILC family WP3893,0.8403528516640444,0.5929899856938483,0.1031407725853148,['NFIL3'],0.9978332419385398,0,0,1
245,Genes related to primary cilium development (based on CRISPR) WP4536,0.8403528516640444,0.5929899856938483,0.1031407725853148,['WDR34'],0.9978332419385398,0,0,1
246,IL-3 signaling pathway WP286,0.8403528516640444,0.5929899856938483,0.1031407725853148,['TGFB1'],0.9978332419385398,0,0,1
247,IL-4 signaling pathway WP395,0.8403528516640444,0.5929899856938483,0.1031407725853148,['NFIL3'],0.9978332419385398,0,0,1
248,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8403528516640444,0.5929899856938483,0.1031407725853148,['PRKCD'],0.9978332419385398,0,0,1
249,Matrix Metalloproteinases WP129,0.8403528516640444,0.5929899856938483,0.1031407725853148,['MMP16'],0.9978332419385398,0,0,1
250,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8403528516640444,0.5929899856938483,0.1031407725853148,['B3GALT2'],0.9978332419385398,0,0,1
251,NRF2-ARE regulation WP4357,0.8403528516640444,0.5929899856938483,0.1031407725853148,['AIMP2'],0.9978332419385398,0,0,1
252,Nuclear receptors WP170,0.8403528516640444,0.5929899856938483,0.1031407725853148,['NR2F2'],0.9978332419385398,0,0,1
253,Ovarian infertility WP34,0.8403528516640444,0.5929899856938483,0.1031407725853148,['INHA'],0.9978332419385398,0,0,1
254,Oxidative Damage WP3941,0.8403528516640444,0.5929899856938483,0.1031407725853148,['CYCS'],0.9978332419385398,0,0,1
255,Phytochemical activity on NRF2 transcriptional activation WP3,0.8403528516640444,0.5929899856938483,0.1031407725853148,['AIMP2'],0.9978332419385398,0,0,1
256,Prion disease pathway WP3995,0.8403528516640444,0.5929899856938483,0.1031407725853148,['RFX5'],0.9978332419385398,0,0,1
257,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8403528516640444,0.5929899856938483,0.1031407725853148,['BAX'],0.9978332419385398,0,0,1
258,B Cell Receptor Signaling Pathway WP23,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['CD81', 'PRKCD']",0.9978332419385398,0,0,2
259,Chemokine signaling pathway WP3929,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['GNG4', 'PRKCD']",0.9978332419385398,0,0,2
260,Genotoxicity pathway WP4286,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['RPS27', 'PHLDA3']",0.9978332419385398,0,0,2
261,Head and Neck Squamous Cell Carcinoma WP4674,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['CDKN2A', 'FGFR2']",0.9978332419385398,0,0,2
262,Imatinib and Chronic Myeloid Leukemia WP3640,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['KIT', 'PIM1']",0.9978332419385398,0,0,2
263,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['TGFB1', 'FGFR2']",0.9978332419385398,0,0,2
264,Photodynamic therapy-induced unfolded protein response WP3613,0.8456865576061302,0.5924068767908309,0.09929123567794844,"['DDIT3', 'DNAJB9']",0.9978332419385398,0,0,2
265,G Protein Signaling Pathways WP35,0.8611849158220442,0.5918220946915351,0.08844546189484997,"['PRKAR1A', 'GNG4', 'PRKCD']",0.9978332419385398,0,0,3
266,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8770742520548085,0.5912356321839081,0.07754860828815313,"['PRKAR1A', 'SST', 'ATP1A3', 'AQP4']",0.9978332419385398,0,0,4
267,Wnt signaling WP428,0.9047928452021119,0.47335243553008594,0.047358561752193426,"['SFRP1', 'ROR2']",0.9978332419385398,0,0,2
268,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9047928452021119,0.47335243553008594,0.047358561752193426,"['SFRP1', 'ROR2']",0.9978332419385398,0,0,2
269,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9047928452021119,0.47335243553008594,0.047358561752193426,"['SFRP1', 'ROR2']",0.9978332419385398,0,0,2
270,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9047928452021119,0.47335243553008594,0.047358561752193426,"['IFI27L2', 'PRKCD']",0.9978332419385398,0,0,2
271,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9047928452021119,0.47335243553008594,0.047358561752193426,"['PSMD8', 'PSMC5']",0.9978332419385398,0,0,2
272,TGF-beta Signaling Pathway WP366,0.9089350584103275,0.5066612010657922,0.04837683746205937,"['TGFB1', 'PARD6A', 'SUMO1']",0.9978332419385398,0,0,3
273,DNA damage response (only ATM dependent) WP710,0.9089350584103275,0.5066612010657922,0.04837683746205937,"['TGFB1', 'CDKN2A', 'BAX']",0.9978332419385398,0,0,3
274,Ebola Virus Pathway on Host WP4217,0.9089350584103275,0.5066612010657922,0.04837683746205937,"['VPS4A', 'HLA-B', 'MERTK']",0.9978332419385398,0,0,3
275,Osteoblast differentiation WP4787,0.9089350584103275,0.5066612010657922,0.04837683746205937,"['PRKCD', 'FGF1', 'FGFR2']",0.9978332419385398,0,0,3
276,Target Of Rapamycin (TOR) Signaling WP1471,0.9134891243556301,0.3948497854077253,0.035727512448951865,['RRAGA'],0.9978332419385398,0,0,1
277,BDNF-TrkB Signaling WP3676,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TRPC3'],0.9978332419385398,0,0,1
278,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TGFB1'],0.9978332419385398,0,0,1
279,Bladder cancer WP2828,0.9134891243556301,0.3948497854077253,0.035727512448951865,['CDKN2A'],0.9978332419385398,0,0,1
280,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TGFB1'],0.9978332419385398,0,0,1
281,Unfolded protein response WP4925,0.9134891243556301,0.3948497854077253,0.035727512448951865,['DDIT3'],0.9978332419385398,0,0,1
282,DNA Replication WP466,0.9134891243556301,0.3948497854077253,0.035727512448951865,['POLE2'],0.9978332419385398,0,0,1
283,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TGFB1'],0.9978332419385398,0,0,1
284,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.9134891243556301,0.3948497854077253,0.035727512448951865,['CD81'],0.9978332419385398,0,0,1
285,Genes controlling nephrogenesis WP4823,0.9134891243556301,0.3948497854077253,0.035727512448951865,['FGFR2'],0.9978332419385398,0,0,1
286,Integrated Cancer Pathway WP1971,0.9134891243556301,0.3948497854077253,0.035727512448951865,['BAX'],0.9978332419385398,0,0,1
287,Interleukin-11 Signaling Pathway WP2332,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TGFB1'],0.9978332419385398,0,0,1
288,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9134891243556301,0.3948497854077253,0.035727512448951865,['RAB3A'],0.9978332419385398,0,0,1
289,Leptin signaling pathway WP2034,0.9134891243556301,0.3948497854077253,0.035727512448951865,['BAX'],0.9978332419385398,0,0,1
290,Male infertility WP4673,0.9134891243556301,0.3948497854077253,0.035727512448951865,['TEX15'],0.9978332419385398,0,0,1
291,miR-509-3p alteration of YAP1/ECM axis WP3967,0.9134891243556301,0.3948497854077253,0.035727512448951865,['COL5A1'],0.9978332419385398,0,0,1
292,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9134891243556301,0.3948497854077253,0.035727512448951865,['OMG'],0.9978332419385398,0,0,1
293,Regulation of Microtubule Cytoskeleton WP2038,0.9134891243556301,0.3948497854077253,0.035727512448951865,['PARD6A'],0.9978332419385398,0,0,1
294,Regulation of toll-like receptor signaling pathway WP1449,0.9134891243556301,0.3948497854077253,0.035727512448951865,['PELI3'],0.9978332419385398,0,0,1
295,Breast cancer pathway WP4262,0.9163499496313636,0.524904214559387,0.045854029223462545,"['KIT', 'BAX', 'FGF1', 'GADD45G']",0.9978332419385398,0,0,4
296,Vitamin D Receptor Pathway WP2877,0.9163499496313636,0.524904214559387,0.045854029223462545,"['SFRP1', 'TGFB1', 'IGFBP5', 'CDKN2A']",0.9978332419385398,0,0,4
297,Insulin Signaling WP481,0.9163499496313636,0.524904214559387,0.045854029223462545,"['PRKCD', 'SGK1', 'PFKM', 'ARF6']",0.9978332419385398,0,0,4
298,Nuclear Receptors Meta-Pathway WP2882,0.9227934574584327,0.6193745232646835,0.04976664544733516,"['PSMC5', 'HSP90AA1', 'TGFB1', 'SLC39A11', 'AIP', 'BAX', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9978332419385398,0,0,10
299,Regulation of Actin Cytoskeleton WP51,0.9412707415550615,0.44279053084648495,0.026799659512830285,"['TMSB4X', 'FGF1', 'FGFR2']",0.9978332419385398,0,0,3
300,Development of ureteric collection system WP5053,0.9421672963965745,0.3939828080229226,0.023470510553482635,"['GDF11', 'FGFR2']",0.9978332419385398,0,0,2
301,Metapathway biotransformation Phase I and II WP702,0.9421672963965745,0.3939828080229226,0.023470510553482635,"['GPX4', 'GSS']",0.9978332419385398,0,0,2
302,Statin inhibition of cholesterol production WP430,0.9531464191244868,0.2957796852646638,0.01419350489933824,['APOE'],0.9978332419385398,0,0,1
303,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9531464191244868,0.2957796852646638,0.01419350489933824,['TMSB4X'],0.9978332419385398,0,0,1
304,DNA IR-damage and cellular response via ATR WP4016,0.9531464191244868,0.2957796852646638,0.01419350489933824,['FANCI'],0.9978332419385398,0,0,1
305,Folate Metabolism WP176,0.9531464191244868,0.2957796852646638,0.01419350489933824,['GPX4'],0.9978332419385398,0,0,1
306,MET in type 1 papillary renal cell carcinoma WP4205,0.9531464191244868,0.2957796852646638,0.01419350489933824,['RPL11'],0.9978332419385398,0,0,1
307,miRNA targets in ECM and membrane receptors WP2911,0.9531464191244868,0.2957796852646638,0.01419350489933824,['COL5A1'],0.9978332419385398,0,0,1
308,p38 MAPK Signaling Pathway WP400,0.9531464191244868,0.2957796852646638,0.01419350489933824,['DDIT3'],0.9978332419385398,0,0,1
309,PPAR signaling pathway WP3942,0.9531464191244868,0.2957796852646638,0.01419350489933824,['FABP3'],0.9978332419385398,0,0,1
310,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9653049734427955,0.3372902169463774,0.011910119919218094,"['RAB3A', 'PRKCD']",0.9978332419385398,0,0,2
311,ESC Pluripotency Pathways WP3931,0.9653049734427955,0.3372902169463774,0.011910119919218094,"['FGF1', 'FGFR2']",0.9978332419385398,0,0,2
312,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9746382014358846,0.2363376251788269,0.006071265979960549,['TGFB1'],0.9978332419385398,0,0,1
313,TGF-beta Receptor Signaling WP560,0.9746382014358846,0.2363376251788269,0.006071265979960549,['TGFB1'],0.9978332419385398,0,0,1
314,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9746382014358846,0.2363376251788269,0.006071265979960549,['TGFB1'],0.9978332419385398,0,0,1
315,Glucocorticoid Receptor Pathway WP2880,0.9746382014358846,0.2363376251788269,0.006071265979960549,['HSP90AA1'],0.9978332419385398,0,0,1
316,"GPCRs, Other WP117",0.9746382014358846,0.2363376251788269,0.006071265979960549,['ACKR1'],0.9978332419385398,0,0,1
317,p53 transcriptional gene network WP4963,0.9746382014358846,0.2363376251788269,0.006071265979960549,['BAX'],0.9978332419385398,0,0,1
318,Phosphodiesterases in neuronal function WP4222,0.9746382014358846,0.2363376251788269,0.006071265979960549,['PDE3A'],0.9978332419385398,0,0,1
319,Circadian rhythm related genes WP3594,0.9765651888131301,0.3533715925394548,0.008379773827822666,"['NFIL3', 'CRH', 'RPS27A']",0.9978332419385398,0,0,3
320,Adipogenesis WP236,0.9854470083660141,0.32085561497326204,0.004703719300488665,"['WWTR1', 'TGFB1', 'DDIT3']",0.9978332419385398,0,0,3
321,Monoamine GPCRs WP58,0.9862789283946279,0.19670958512160228,0.002717754488788162,['HTR5A'],0.9978332419385398,0,0,1
322,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9862789283946279,0.19670958512160228,0.002717754488788162,['TGFB1'],0.9978332419385398,0,0,1
323,"GPCRs, Class A Rhodopsin-like WP455",0.9901057086926964,0.33538587848932677,0.0033349313151828123,"['MC1R', 'P2RY14', 'HTR5A', 'MCHR1']",0.9978332419385398,0,0,4
324,Wnt signaling pathway and pluripotency WP399,0.9925804452910979,0.1684038422235847,0.0012541398750644341,['PRKCD'],0.9978332419385398,0,0,1
325,Oncostatin M Signaling Pathway WP2374,0.9959897517940902,0.14717453505007153,0.0005913930257132699,['PRKCD'],0.9978332419385398,0,0,1
326,Focal Adhesion WP306,0.9976203329075034,0.19555873925501432,0.00046591928297792237,"['PDGFC', 'VEGFB']",0.9978332419385398,0,0,2
327,Ciliopathies WP4803,0.9978332419385398,0.1306628516928946,0.0002834219516435791,['WDR34'],0.9978332419385398,0,0,1
328,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9978332419385398,0.1306628516928946,0.0002834219516435791,['TGFB1'],0.9978332419385398,0,0,1
329,Endochondral Ossification WP474,0.9978332419385398,0.1306628516928946,0.0002834219516435791,['TGFB1'],0.9978332419385398,0,0,1
